Methods and host cells for improved cell culture

Details Methods and host cells for improved cell culture Methods and host cells for improved cell culture

2005-05-24

2005-05-24

Leffers, Gerry (Department: 1636)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S325000, C435S358000, C435S360000, C435S455000, C435S254200, C435S070100, C435S069700

Reexamination Certificate

active

06897040

ABSTRACT:
The invention provides improved methods of recombinant protein production in cell culture. More specifically, the invention relates to the modulation of the IGF-1 signaling pathway in cells so as to improve production characteristics.

REFERENCES:
patent: 5597719 (1997-01-01), Freed et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5663314 (1997-09-01), Seger et al.
patent: 6232117 (2001-05-01), Mather
patent: 6235498 (2001-05-01), Mather et al.
patent: 6413744 (2002-07-01), Morris et al.
patent: 0496453 (1992-07-01), None
patent: 0666312 (1995-08-01), None
patent: WO 9320200 (1993-10-01), None
patent: WO 9705240 (1997-02-01), None
patent: WO 9916887 (1999-04-01), None
Alessandrini et al. J. Biol. Chem., 1996, 271(49): 31612-18.*
Ahmed et al. PNAS, 1997, 94:3627-32.*
Skorski et al. EMBO, 1997, 16:6151-61.*
Alessi et al., “Mechanism of Activation of Protein Kinase B By Insulin and IGF-1,”The EMBO Journal15(23):6541-6551, 1996.
Bailey, J. E. et al., “Inverse Metabolic Engineering: A Strategy for Directed Genetic Engineering of Useful Phenotypes,”Biotechnology and Bioengineering, 52:109-121, 1996.
Brott, B. K. et al., “MEK2 Is a Kinase Related to MEK1 and Is Differentially Expressed in Murine Tissues,”Cell Growth&Differentiation, 4:921-929, 1993.
Butler, A. A. et al., “Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology,”Comparative Biochemistry and Physiology, Part B, 121:19-26, 1998.
Coffer, P. J. et al, “Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation,”Biochem. J., 335:1-13, 1998.
Datta, S. R. et al., “Cellular survival: a play in three Akts,”Genes&Development, 13(22):2905-2927.
Furlanetto, R. W. et al., “14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor,”Biochem. J., 327:765-771, 1997.
Fussenegger, M. and Bailey, J. E., “Control of Mammalian Cell Proliferation as an Important Strategy in Cell Culture Technology, Cancer Therapy and Tissue Engineering,”Cell Engineering, Mohamed Al-Rubeai, ed., Kluwer Academic, Dordrecht, Boston, London, 1999, pp. 186-219.
Fussenegger, M. and Bailey, J. E., “Molecular Regulation of Cell-Cycle Progression and Apoptosis in Mammalian Cells: Implications for Biotechnology,”Biotechnol. Prog., 14(6):807-833, 1998.
Fussenegger, M. and Bailey, J. E., “Genetic optimization of recombinant glycoprotein production by mammalian cells,”Tibech, 17:35-42, 1999.
Galetic, I. et al., “Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer,”Pharmacol. Ther., 82(2-3):409-425, 1999.
Greulich, H. and Erikson, R. L., “An Analysis of Mek1 Signaling in Cell Proliferation and Transformation,”The Journal of Biological Chemistry, 273(21):13280-13288, 1998.
Hannigan, G. E. et al., “Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase,”Nature, 379:91-96, 1996.
Hsu, S. Y. et al., “Interference of BAD (Bcl-xL/Bcl-2-Associated Death Promoter)—Induced Apoptosis in Mammalian Cells by 14-3-3 Isoforms and P11,”Molecular Endocrinology, 11(12):1858-1865, 1997.
Klippel, A. et al., Membrane Localization of Phosphatidylinositol 3-Kinase is Sufficient to Activate Multiple Signal-Transducing Kinase Pathways,Molecular and Cellular Biology, 16(8):4117-4127, 1996.
Konishi, H. et al., “Opposing Effects of Protein Kinase C δ and Protein Kinase B α on H2O2-Induced Apoptosis in CHO Cells,”Biochemical and Biophysical Research Communications, 264:840-846, 1999.
Lee, K. H. et al., “Deregulated Expression of Cloned Transcription Factor E2F-1 in Chinese Hamster Ovary Cells Shifts Protein Patterns and Activates Growth in Protein-Free Medium,”Biotechnology and Bioengineering, 50:273-279, 1996.
Le Gall, M. et al., “The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal,”Molecular Biology of the Cell, 11(3):1103-1112, 2000.
Lopaczynski, W., “Differential regulation of signaling pathways for insulin and insulin-like growth factor I,”Acta Biochimica Polonica, 46(1):51-60, 1999.
Madrid, L.V., et al., “Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NK-κB,”Molecular and Cellular Biology 20(5):1626-1638 (2000).
Mueckler, M., “Facilitative glucose transporters,”Eur. J. Biochem., 219:713-725, 1994.
O'Connor, R. et al., “Identification of Domains of the Insulin-Like Growth Factor I Receptor That Are Required for Protection from Apoptosis,”Molecular and Cellular Biology, 17(1):427-435, 1997.
Owaki, H. et al., “Extracellular Signal-Regulated Kinases in T Cells: Characterization of Human ERK1 and ERK2 cDNAs1,2,”Biochemical and Biophysical Research Communications, 182(3):1416-1422, 1992.
Ozes, O. N. et al., “NF-κ B activation by tumour necrosis factor requires the Akt serine-threonine kinase,”Nature, 401:82-85, 1999.
Pages, G. et al., “Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK 1),”EMBO Journal, 13(13) :3003-3010, 1994.
Pak, S. C. O. et al., “Super-CHO—A cell line capable of autocrine growth under fully defined protein-free conditions,”Cytochnology, 22:139-146, 1996.
Paul, A. et al., “Stress-activated Protein Kinases: Activation, Regulation and Function,”Cell. Signal., 9(6):403-410, 1997.
Pelech, S. L., “MAP kinase-dependent pathways in cell cycle control,”Prog. Cell Cycle Res., 1:33-52, 1995, Abstract.
Rasmussen, B. et al., “Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line,”Cytotechnology, 28:31-42, 1998.
Romashkova, J. A. and Makarov, S. S, “NF-κB is a target of AKT in anti-apoptotic PDGF signalling,”Nature, 401:86-89, 1999.
Samadder, P. and Arthur, G., “Decreased Sensitivity to 1-O-Octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 Cells Adapted for Serum-free Growth Correlates with Constitutive Association of Raf-1 with Cellular Membranes,”Cancer Research, 59:4808-4815, 1999.
Tang, Y. et al., “The Akt proto-oncogene links Ras to Pak and cell survival signals,”Journal of Biological Chemistry, 275(13):9106-9109, 2000, Abstract.
Waters, S. B. and Pessin, J. E., “Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave,”Cell Biology, 6:1-4, 1996.
Woessmann, W. et al., “An essential role for mitogen-activated protein kinases, ERKs, in preventing heat-induced cell death,”Journal of Cellular Biochemistry, 74(4):648-662, 1999, Abstract.
Yip-Schneider, M. T. et al., “Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression,”International Journal of Oncology, 15(2):271-279, 1999, Abstract.
Zanghi, J. A. et al., “Serum Protects Protein-Free Competent Chinese Hamster Ovary Cells Against Apoptosis Induced by Nutrient Deprivation in Batch Culture,”Biotechnology and Bioengineering, 64(1):108-120, 1999.

Affiliated with

Also associated with

Rating

Methods and host cells for improved cell culture does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and host cells for improved cell culture, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and host cells for improved cell culture will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3379080